Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 2 | 2005 | 84 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 688 | 0.280 |
Why?
|
| Takayasu Arteritis | 1 | 2005 | 4 | 0.230 |
Why?
|
| Vasculitis | 1 | 2005 | 40 | 0.230 |
Why?
|
| Uveitis | 1 | 2005 | 35 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 36 | 0.220 |
Why?
|
| Tramadol | 1 | 2005 | 14 | 0.220 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 51 | 0.220 |
Why?
|
| Acetaminophen | 1 | 2005 | 61 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 1395 | 0.200 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 513 | 0.160 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2016 | 292 | 0.150 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 1997 | 13 | 0.130 |
Why?
|
| Sarcoidosis | 2 | 2007 | 92 | 0.120 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 75 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2016 | 372 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 1997 | 352 | 0.110 |
Why?
|
| Dermatomyositis | 2 | 2016 | 20 | 0.110 |
Why?
|
| Knee Joint | 1 | 1994 | 161 | 0.100 |
Why?
|
| Joint Instability | 1 | 1994 | 99 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 990 | 0.090 |
Why?
|
| Infliximab | 3 | 2007 | 162 | 0.080 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1991 | 30 | 0.080 |
Why?
|
| Spondylarthropathies | 1 | 2010 | 3 | 0.080 |
Why?
|
| Cryoglobulinemia | 1 | 2010 | 5 | 0.080 |
Why?
|
| Thalidomide | 1 | 2010 | 55 | 0.080 |
Why?
|
| Polymyositis | 1 | 2009 | 7 | 0.080 |
Why?
|
| Amyloidosis | 1 | 1991 | 129 | 0.070 |
Why?
|
| Antibodies, Antinuclear | 1 | 2009 | 94 | 0.070 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2008 | 10 | 0.070 |
Why?
|
| Calcinosis | 1 | 2008 | 222 | 0.060 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2007 | 2 | 0.060 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2007 | 20 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 249 | 0.060 |
Why?
|
| Retinal Diseases | 1 | 2007 | 84 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 338 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2007 | 174 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 38 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2005 | 35 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 99 | 0.050 |
Why?
|
| Dermatologic Agents | 1 | 2005 | 77 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2005 | 200 | 0.050 |
Why?
|
| Adult | 8 | 2016 | 27918 | 0.050 |
Why?
|
| Radiography | 2 | 2016 | 790 | 0.050 |
Why?
|
| Respiratory Function Tests | 2 | 2016 | 155 | 0.050 |
Why?
|
| Humans | 12 | 2016 | 93501 | 0.040 |
Why?
|
| Middle Aged | 6 | 2016 | 27569 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1103 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 353 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 2302 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1264 | 0.030 |
Why?
|
| Female | 6 | 2016 | 48696 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1997 | 69 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1997 | 66 | 0.030 |
Why?
|
| Aged | 5 | 2016 | 20430 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1997 | 278 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2016 | 11 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 73 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 1997 | 268 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 262 | 0.030 |
Why?
|
| Rotation | 1 | 1994 | 90 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 289 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 759 | 0.030 |
Why?
|
| Male | 6 | 2016 | 44552 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2016 | 10163 | 0.020 |
Why?
|
| Movement | 1 | 1994 | 304 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 125 | 0.020 |
Why?
|
| Amyloid | 1 | 1991 | 104 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sacroiliac Joint | 1 | 2010 | 11 | 0.020 |
Why?
|
| Pregnancy | 1 | 1997 | 3147 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 7061 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 91 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 9097 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 170 | 0.020 |
Why?
|
| Etanercept | 1 | 2007 | 34 | 0.020 |
Why?
|
| Mouth Diseases | 1 | 2007 | 14 | 0.020 |
Why?
|
| Fundus Oculi | 1 | 2007 | 28 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2007 | 27 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 83 | 0.020 |
Why?
|
| Biopsy | 1 | 1991 | 1175 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2010 | 358 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 1111 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 578 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 464 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 428 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 757 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 6930 | 0.010 |
Why?
|